Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China.
Anal Chem. 2024 Nov 12;96(45):18187-18194. doi: 10.1021/acs.analchem.4c04366. Epub 2024 Nov 1.
With the aim of efficiently sorting rare circulating tumor cells (CTCs) from blood and minimizing damage to CTCs during isolation, we constructed an inertia-assisted single-cell focusing generator (I-SCF) and a water droplet deterministic lateral displacement cell sorting (D-DLD) microfluidic system (IDIC) based on different sizes, the device is initially sorted by a continuous fluid swing and Dean flow-assisted helical micromixers, then flows through a droplet shaped DLD region, enabling single-cell focused sequencing and precise separation, improving cell separation efficiency (>95%) and purity, while ensuring a high single cells survival rate of more than 98.6%. Subsequently, breast cancer cell lines were run through our chip, and then the downstream epithelial-mesenchymal transition (EMT) process induced by TGF-β was detected, and the levels of three proteins, EpCAM, PD-L1, and N-cadherin, were analyzed to establish the relationship between PD-L1 and the EMT process. Compared with other analytical techniques such as the filtration method, the enrichment method and immunoaffinity capture methods, this method not only ensures the separation efficiency and purity, but also ensures the cell activity, and avoids missing the different results caused by the heterogeneity of CTCs due to the isolation of high purity (84.01%). The device has a high throughput processing capacity (5 mL of diluted whole blood/∼2.8 h). By using the chip, we can more easily and conveniently predict tumor stage and carry out cancer prevention and treatment in advance, and it is expected to be further developed into a clinical liquid biopsy technology in the future.
为了高效地从血液中分离稀有循环肿瘤细胞(CTC)并在分离过程中尽量减少对 CTC 的损伤,我们构建了基于不同大小的惯性辅助单细胞聚焦发生器(I-SCF)和水滴确定性侧向位移细胞分选(D-DLD)微流控系统(IDIC)。该设备最初通过连续流体摆动和 Dean 流辅助螺旋微混合器进行初步分选,然后流经液滴状 DLD 区域,实现单细胞聚焦测序和精确分离,提高细胞分离效率(>95%)和纯度,同时确保超过 98.6%的高单细胞存活率。随后,将乳腺癌细胞系通过我们的芯片,然后检测 TGF-β诱导的下游上皮-间充质转化(EMT)过程,并分析三种蛋白 EpCAM、PD-L1 和 N-钙黏蛋白的水平,以建立 PD-L1 与 EMT 过程之间的关系。与其他分析技术,如过滤法、富集法和免疫亲和捕获法相比,这种方法不仅确保了分离效率和纯度,还保证了细胞活性,避免了因高纯度(84.01%)分离而错过 CTC 异质性引起的不同结果。该设备具有高通量处理能力(5 毫升稀释全血/∼2.8 小时)。通过使用该芯片,我们可以更轻松、更方便地预测肿瘤分期并提前进行癌症预防和治疗,预计未来将进一步发展成为一种临床液体活检技术。